3 documents found, page 1 of 1
Percutaneous coronary intervention reduces mortality in myocardial infarction p...
Dégano, IR; Subirana, I; Fusco, D; Tavazzi, L; Kirchberger, I; Farmakis, D; Ferrières, J; Azevedo, A; Torre, M; Garel, P; Brosa, M; Davoli, MBackground: Percutaneous coronary intervention (PCI) reduces mortality in most myocardial infarction (MI) patients but the effect on elderly patients with comorbidities is unclear. Our aim was to analyse the effect of PCI on in-hospital mortality of MI patients, by age, sex, ST elevation on presentation, diabetes mellitus (DM) and chronic kidney disease (CKD). Methods: Cohort study of 79,791 MI patients admitte...
A European benchmarking system to evaluate in-hospital mortality rates in acute...
Dégano, IR; Subirana, I; Torre, M; Grau, M; Vila, J; Fusco, D; Kirchberger, I; Ferrieres, J; Malmivaara, A; Azevedo, A; Meisinger, C; Bongard, VBackground: Hospital performance models in acute myocardial infarction (AMI) are useful to assess patient management. While models are available for individual countries, mainly US, cross-European performance models are lacking. Thus, we aimed to develop a system to benchmark European hospitals in AMI and percutaneous coronary intervention (PCI), based on predicted in-hospital mortality. Methods and results: We...
Age and sex inequalities in the prescription of evidence-based pharmacological ...
Pereira, M; Araújo, C; Dias, P; Lunet, N; Subirana, I; Marrugat, J; Capewell, S; Bennett, K; Azevedo, AAim: To assess the proportion of patients receiving pharmacological therapy for secondary prevention after an acute coronary syndrome (ACS) in Portugal and to identify age and sex inequalities. Design: Retrospective cohort study. Methods: We studied 747 episodes of ST-segment elevation myocardial infarction (STEMI) and 1364 of non-ST-segment elevation ACS (NSTE-ACS), within a sample of ACS cases consecutively d...